205 related articles for article (PubMed ID: 15044621)
1. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide induces breakdown of phosphatidylinositol phosphates in cultured vascular smooth-muscle cells.
Resink TJ; Scott-Burden T; Baur U; Jones CR; Bühler FR
Eur J Biochem; 1988 Mar; 172(2):499-505. PubMed ID: 2894985
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester modulation of cyclic AMP accumulation in a primary culture of rat aortic smooth muscle cells.
Phaneuf S; Berta P; Peuch LP; Haiech J; Cavadore JC
J Pharmacol Exp Ther; 1988 Jun; 245(3):1042-7. PubMed ID: 2838600
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane signalling of atrial natriuretic peptide in rat renal juxtaglomerular cells.
Kurtz A
Klin Wochenschr; 1986; 64 Suppl 6():37-41. PubMed ID: 2879065
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cyclic AMP accumulation and morphological changes induced by beta-adrenergic stimulation of cultured vascular smooth muscle cells and fibroblasts.
Nabika T; Velletri PA; Igawa T; Yamori Y; Lovenberg W
Blood Vessels; 1985; 22(1):47-56. PubMed ID: 2857102
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells.
Leitman DC; Agnost VL; Catalano RM; Schröder H; Waldman SA; Bennett BM; Tuan JJ; Murad F
Endocrinology; 1988 Apr; 122(4):1478-85. PubMed ID: 2894298
[TBL] [Abstract][Full Text] [Related]
8. Regulation of phosphorylase A formation and calcium content in aortic smooth muscle and smooth muscle cells: effects of atrial natriuretic peptide II.
Cornwell TL; Lincoln TM
J Pharmacol Exp Ther; 1988 Nov; 247(2):524-30. PubMed ID: 2846823
[TBL] [Abstract][Full Text] [Related]
9. Modulation of ANP receptor-mediated cGMP accumulation by atrial natriuretic peptides and vasopressin in A10 vascular smooth muscle cells.
Bellemann P; Neuser D
J Recept Res; 1988; 8(1-4):407-17. PubMed ID: 2898530
[TBL] [Abstract][Full Text] [Related]
10. Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation.
Nambi P; Whitman M; Stassen FL; Crooke ST
J Pharmacol Exp Ther; 1986 Apr; 237(1):143-6. PubMed ID: 3007735
[TBL] [Abstract][Full Text] [Related]
11. A comparison of cyclic AMP signaling system in rat aortic myocytes in primary culture and aorta.
Schoeffter P; Lugnier C; Travo C; Stoclet JC
Lab Invest; 1989 Aug; 61(2):177-82. PubMed ID: 2474090
[TBL] [Abstract][Full Text] [Related]
12. Activation of beta-adrenergic receptors causes stimulation of cyclic AMP, inhibition of inositol trisphosphate, and relaxation of bovine iris sphincter smooth muscle. Biochemical and functional interactions between the cyclic AMP and calcium signalling systems.
Tachado SD; Akhtar RA; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2232-9. PubMed ID: 2551839
[TBL] [Abstract][Full Text] [Related]
13. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase.
Felder CC; Jose PA; Axelrod J
J Pharmacol Exp Ther; 1989 Jan; 248(1):171-5. PubMed ID: 2563286
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells.
Leitman DC; Andresen JW; Catalano RM; Waldman SA; Tuan JJ; Murad F
J Biol Chem; 1988 Mar; 263(8):3720-8. PubMed ID: 2894373
[TBL] [Abstract][Full Text] [Related]
15. Biologically active atrial natriuretic peptides selectively activate Na/K/Cl cotransport in vascular smooth muscle cells.
O'Donnell ME; Bush EN; Holleman W; Owen NE
J Pharmacol Exp Ther; 1987 Dec; 243(3):822-8. PubMed ID: 2826759
[TBL] [Abstract][Full Text] [Related]
16. The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion.
Barrett PQ; Isales CM
Endocrinology; 1988 Mar; 122(3):799-808. PubMed ID: 2830096
[TBL] [Abstract][Full Text] [Related]
17. Effect of synthetic atrial natriuretic peptide on rat renal juxtaglomerular cells.
Kurtz A; Della Bruna R; Pfeilschifter J; Bauer C
J Hypertens Suppl; 1986 Jun; 4(2):S57-60. PubMed ID: 3014096
[TBL] [Abstract][Full Text] [Related]
18. Role of guanine nucleotide regulatory protein in polyphosphoinositide degradation and activation of phagocytic leukocytes by chemoattractants.
Verghese MW; Smith CD; Snyderman R
J Cell Biochem; 1986; 32(1):59-69. PubMed ID: 3021789
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation.
Yoshimasa T; Sibley DR; Bouvier M; Lefkowitz RJ; Caron MG
Nature; 1987 May 7-13; 327(6117):67-70. PubMed ID: 3033513
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide-dependent phosphorylation of smooth muscle cell particulate fraction proteins is mediated by cGMP-dependent protein kinase.
Sarcevic B; Brookes V; Martin TJ; Kemp BE; Robinson PJ
J Biol Chem; 1989 Dec; 264(34):20648-54. PubMed ID: 2573602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
